AstraZeneca
Israeli-founded AI biotech Immunai expands AstraZeneca cancer collaboration
The expanded agreement extends and broadens the companies’ multi-year collaboration in oncology through 2027, according to the statement.
Immunai, AstraZeneca collaborate to optimize cancer clinical trials
US to move COVID-19 vaccines, treatments to private markets in 2023
AION, aMoon up for top scientific innovation award
AstraZeneca COVID-19 antibody drug offers 83% protection over six months
The Anglo-Swedish company also said that patients with mild-to-moderate COVID-19 showed a higher dose of the drug cut the risk of symptoms worsening by 88% when given within three days.
'Our COVID vaccine as good or better than AstraZeneca's' - Valneva
A study showed that Valneva's vaccine, given in two shots 28 days apart, prompted significantly fewer adverse reactions, such as arm pain and fever.
COVID: Israel to give AstraZeneca vaccine to those affected by Pfizer
The country is on the cusp of 8,000 deaths since the beginning of the pandemic.
EU begins reviewing AstraZeneca's COVID-19 antibody cocktail
The medicine has proven to work in the non-infected and was also shown to save lives and prevent severe disease when given as treatment within a week of first symptoms.
COVID vaccines: Pfizer, AstraZeneca, Sputnik V more effective than Sinopharm - study
According to the study, which included the data of more than one million people, the Chinese-developed Sinopharm vaccine was less suitable for those over 50 years old.
EU lists rare nerve disorder as possible side-effect of AstraZeneca COVID-19 vaccine
The European Medicines Agency also tagged some other less severe side-effects to vaccines from Johnson & Johnson, Moderna as well as AstraZeneca's shot.
What you need to know about the coronavirus right now
A new variant has been detected in South Africa, the EU has vaccinated 70% of its adults, and more - here's what you need to know about COVID-19
Barbie debuts British COVID-19 vaccine developer doll
Gilbert, a 59-year-old professor at Oxford University and co-developer of the Oxford/AstraZeneca vaccine, is one of six women in the COVID-19 fight who have new Barbies modeled after them.
Combining AstraZeneca, mRNA COVID-19 vaccines 88% effective - Danish study
"The study shows that fourteen days after a combined vaccination program, the risk of infection with SARS-CoV-2 is reduced by 88% compared to unvaccinated individuals," the State Serum Institute said
Vietnam to mix doses of Pfizer, AstraZeneca COVID-19 vaccines
A Spanish study found the Pfizer-AstraZeneca combination was highly safe and effective, according to preliminary results.
